Sittner & Nelson’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
39,909
+902
+2% +$24K 0.41% 58
2025
Q4
$1.06M Buy
39,007
+1,045
+3% +$26.4K 0.38% 57
2025
Q3
$967K Sell
37,962
-6,764
-15% -$167K 0.35% 52
2025
Q2
$1.08M Sell
44,726
-1,131
-2% -$26.4K 0.44% 45
2025
Q1
$1.16M Buy
45,857
+2,832
+7% +$74.1K 0.5% 36
2024
Q4
$1.14M Sell
43,025
-11,308
-21% -$307K 0.49% 38
2024
Q3
$1.57M Sell
54,333
-4,097
-7% -$120K 0.7% 28
2024
Q2
$1.63M Sell
58,430
-5,742
-9% -$158K 0.81% 27
2024
Q1
$1.78M Buy
64,172
+1,837
+3% +$51K 0.9% 26
2023
Q4
$1.79M Buy
62,335
+4,567
+8% +$138K 0.96% 24
2023
Q3
$1.92M Buy
57,768
+9,049
+19% +$320K 1.1% 23
2023
Q2
$1.79M Sell
48,719
-5,800
-11% -$226K 0.98% 23
2023
Q1
$2.22M Buy
54,519
+1,397
+3% +$60.3K 1.28% 13
2022
Q4
$2.72M Buy
53,122
+758
+1% +$36.3K 1.66% 10
2022
Q3
$2.29M Buy
52,364
+769
+1% +$37.4K 1.54% 9
2022
Q2
$2.71M Buy
51,595
+9,844
+24% +$502K 1.77% 8
2022
Q1
$2.16M Buy
41,751
+781
+2% +$40.5K 1.25% 18
2021
Q4
$2.42M Buy
40,970
+6,842
+20% +$339K 1.41% 16
2021
Q3
$1.47M Sell
34,128
-292
-0.8% -$12.9K 0.95% 27
2021
Q2
$1.35M Buy
34,420
+3,411
+11% +$133K 0.95% 26
2021
Q1
$1.12M Buy
31,009
+1,816
+6% +$64.5K 0.84% 32
2020
Q4
$1.07M Buy
+29,193
New +$1.07M 0.96% 29

Other funds holding PFE

Sittner & Nelson's PFE Position: Q1 2026 in Review

Sittner & Nelson increased its Pfizer (PFE) stake by 2.3% in Q1 2026, buying an estimated $24K and bringing the position to 39,909 shares worth $1.12M. The position accounts for 0.41% of the portfolio, ranked #58.

Sittner & Nelson first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.72M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sittner & Nelson held 39,909 shares of Pfizer worth $1.12M as of Q1 2026.
  • Sittner & Nelson bought 902 Pfizer shares in Q1 2026, an estimated $24K.
  • Pfizer made up 0.41% of Sittner & Nelson's portfolio in Q1 2026, its #58 holding.
  • Sittner & Nelson first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Sittner & Nelson's Pfizer position peaked at $2.72M in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.